Voloridge Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-393,636
| Closed | -$103M | – | 1155 |
|
|
2024
Q4 | $103M | Buy |
+393,636
| New | +$117M | 0.36% | 61 |
|
|
2024
Q2 | – | Sell |
-30,383
| Closed | -$8.64M | – | 1189 |
|
|
2024
Q1 | $8.64M | Buy |
+30,383
| New | +$8.89M | 0.03% | 524 |
|
|
2023
Q1 | – | Sell |
-65,037
| Closed | -$17.1M | – | 1346 |
|
|
2022
Q4 | $17.1M | Sell |
65,037
-422,371
| -87% | -$113M | 0.1% | 297 |
|
|
2022
Q3 | $110M | Buy |
487,408
+54,546
| +13% | +$13.2M | 0.59% | 17 |
|
|
2022
Q2 | $105M | Buy |
+432,862
| New | +$106M | 0.54% | 15 |
|
|
2022
Q1 | – | Sell |
-35,177
| Closed | -$7.91M | – | 1342 |
|
|
2021
Q4 | $7.91M | Sell |
35,177
-303,584
| -90% | -$64.1M | 0.04% | 538 |
|
|
2021
Q3 | $72M | Buy |
338,761
+304,182
| +880% | +$70M | 0.46% | 26 |
|
|
2021
Q2 | $8.43M | Buy |
+34,579
| New | +$8.51M | 0.06% | 465 |
|
|
2021
Q1 | – | Sell |
-251,139
| Closed | -$57.7M | – | 1361 |
|
|
2020
Q4 | $57.7M | Buy |
+251,139
| New | +$57.9M | 0.48% | 34 |
|
|
2020
Q3 | – | Sell |
-7,235
| Closed | -$1.71M | – | 1229 |
|
|
2020
Q2 | $1.71M | Buy |
7,235
+5,553
| +330% | +$1.27M | 0.02% | 676 |
|
|
2020
Q1 | $341K | Sell |
1,682
-38,046
| -96% | -$8.31M | 0.01% | 825 |
|
|
2019
Q4 | $9.58M | Sell |
39,728
-9,365
| -19% | -$2.06M | 0.19% | 143 |
|
|
2019
Q3 | $9.5M | Buy |
49,093
+33,839
| +222% | +$6.5M | 0.17% | 131 |
|
|
2019
Q2 | $2.81M | Sell |
15,254
-138,118
| -90% | -$24.7M | 0.08% | 261 |
|
|
2019
Q1 | $29.1M | Buy |
+153,372
| New | +$29.3M | 0.88% | 16 |
|
|
2018
Q4 | – | Sell |
-83,131
| Closed | -$17.2M | – | 403 |
|
|
2018
Q3 | $17.2M | Buy |
+83,131
| New | +$16.4M | 0.38% | 84 |
|
|
2018
Q1 | – | Sell |
-59,159
| Closed | -$10.3M | – | 484 |
|
|
2017
Q4 | $10.3M | Buy |
+59,159
| New | +$10.5M | 0.22% | 115 |
|
|
2016
Q4 | – | Sell |
-101,185
| Closed | -$16.9M | – | 613 |
|
|
2016
Q3 | $16.9M | Buy |
+101,185
| New | +$17.1M | 0.37% | 43 |
|
|
2016
Q2 | – | Sell |
-75,231
| Closed | -$11.3M | – | 288 |
|
|
2016
Q1 | $11.3M | Buy |
+75,231
| New | +$11.2M | 0.26% | 80 |
|
|
2015
Q2 | – | Sell |
-203,867
| Closed | -$32.6M | – | 288 |
|
|
2015
Q1 | $32.6M | Buy |
+203,867
| New | +$32.1M | 1.58% | 13 |
|
Other funds holding AMGN
Voloridge Investment Management's AMGN Position: Q1 2025 in Review
Voloridge Investment Management sold out of Amgen (AMGN) in Q1 2025, closing a stake of 393,636 shares — an estimated $103M sold.
Voloridge Investment Management first reported a position in AMGN in Q1 2015 and held it in 20 quarters. The position peaked at $110M in Q3 2022. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.
- Voloridge Investment Management reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
- Voloridge Investment Management sold 393,636 Amgen shares in Q1 2025, an estimated $103M.
- Voloridge Investment Management first reported a position in Amgen in Q1 2015 and held it in 20 quarters.
- Voloridge Investment Management's Amgen position peaked at $110M in Q3 2022.
- 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.
Based on Voloridge Investment Management's 13F filing for Q1 2025, filed 15 May 2025.